Literature DB >> 22424438

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22424438     DOI： 10.1016/j.jhep.2011.12.001

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  1923 in total

1.  Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.

Authors:  Daniel L Motola; Peter Caravan; Raymond T Chung; Bryan C Fuchs
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

2.  Benefits of laparoscopic liver resection in patients with hepatocellular carcinoma and portal hypertension: a case-matched study.

Authors:  Víctor Molina; Jaime Sampson-Dávila; Joana Ferrer; Constantino Fondevila; Rafael Díaz Del Gobbo; David Calatayud; Jordi Bruix; Juan Carlos García-Valdecasas; Josep Fuster
Journal:  Surg Endosc       Date:  2017-12-07       Impact factor: 4.584

3.  Liver Stiffness Assessed by Shear Wave Elastography Predicts Postoperative Liver Failure in Patients with Hepatocellular Carcinoma.

Authors:  Yinghao Shen; Chenhao Zhou; Guodong Zhu; Guoming Shi; Xiaodong Zhu; Cheng Huang; Jian Zhou; Jia Fan; Hong Ding; Ning Ren; Hui-Chuan Sun
Journal:  J Gastrointest Surg       Date:  2017-05-16       Impact factor: 3.452

4.  Single measurement of hemoglobin predicts outcome of HCC patients.

Authors:  Fabian Finkelmeier; Dominik Bettinger; Verena Köberle; Michael Schultheiß; Stefan Zeuzem; Bernd Kronenberger; Albrecht Piiper; Oliver Waidmann
Journal:  Med Oncol       Date:  2013-12-11       Impact factor: 3.064

5.  Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis.

Authors:  Vincenzo O Palmieri; Daniela Santovito; Francesco Margari; Madia Lozupone; Francesco Minerva; Carla Di Gennaro; Orlando Todarello; Giuseppe Palasciano
Journal:  Clin Exp Med       Date:  2013-12-10       Impact factor: 3.984

6.  Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Jian-Bo Zhao; Chao Feng; Qiao-Hua Zhu; Xiao-Feng He; Yan-Hao Li; Yong Chen
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

Review 7.  Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.

Authors:  Maurizio Pompili; Giampiero Francica; Francesca Romana Ponziani; Roberto Iezzi; Alfonso Wolfango Avolio
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

8.  Primary surgical resection versus liver transplantation for transplant-eligible hepatocellular carcinoma patients.

Authors:  Robert J Wong; James Wantuck; Antonia Valenzuela; Aijaz Ahmed; Clark Bonham; Amy Gallo; Marc L Melcher; Glen Lutchman; Waldo Concepcion; Carlos Esquivel; Gabriel Garcia; Tami Daugherty; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2013-11-27       Impact factor: 3.199

9.  Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.

Authors:  Luciana Kikuchi; Marcos Menezes; Aline L Chagas; Claudia M Tani; Regiane Ssm Alencar; Marcio A Diniz; Venâncio Af Alves; Luiz Augusto Carneiro D'Albuquerque; Flair José Carrilho
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

10.  Advances and Future Directions in the Treatment of Hepatocellular Carcinoma.

Authors:  Ashil J Gosalia; Paul Martin; Patricia D Jones
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.